✦ LIBER ✦

Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study

✍ Scribed by Patrick D. Beauchesne; L. Taillandier; V. Bernier; C. Carnin

Publisher: Springer
Year: 2009
Tongue: English
Weight: 281 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-0993-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of a radiotherapy/etoposi

Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas

✍ P. Beauchesne; C. Soler; P. Rusch; M. J. Fotso; R. Duthel; T. Schmitt; J. Brunon 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 99 KB

Low-dose fotemustine for recurrent malig

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study

✍ Alessandra Fabi; Giulio Metro; Antonello Vidiri; Gaetano Lanzetta; Mariantonia C 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 319 KB

Phase 1 study of concurrent RMP-7 and ca

Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas

✍ Roger J. Packer; Mark Krailo; Minesh Mehta; Katherine Warren; Jeffrey Allen; Reg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Carboplatin and etoposide with hyperfrac

Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: A phase I/II study

✍ Walter, Andrew W.; Gajjar, Amar; Ochs, Judith S.; Langston, James W.; Sanford, R 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Background: Diffuse pontine gliomas remain one of the most lethal of pediatric malignancies despite the use of increasingly intensive therapies. we delivered intensive chemotherapy during and following 70.2 gy of hyperfractionated radiation therapy in an attempt to improve survival. ## Procedur

A Phase I/II study of carboplatin combin

A Phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas

✍ Jeffrey Allen; Joao Siffert; Bernadine Donahue; Anita Nirenberg; Regina Jakacki; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Brainstem gliomas often respond to radiotherapy but long term disease control is exceptional. The concomitant administration of a chemotherapy agent with radiosensitizing properties such as carboplatin may increase the efficacy of radiotherapy.

A Phase I study of concurrent RMP-7 and

A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas

✍ Roger J. Packer; Mark Krailo; Minesh Mehta; Katherine Warren; Jeffrey Allen; Reg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract ## BACKGROUND Ninety percent of children with diffuse, intrinsic brainstem tumors will die within 18 months of diagnosis. Radiotherapy is of transient benefit to these children, and a potential way to improve its efficacy is to add radiosensitizers. Carboplatin is antineoplastic and ra